Introduction of Geftinat 250mg Tablet
Geftinat 250mg Tablet serves as a pivotal treatment option for patients diagnosed with non-small cell lung cancer. By specifically targeting the epidermal growth factor receptor (EGFR), this medication inhibits the signaling pathways that promote cancer cell proliferation, thereby slowing disease progression and improving survival rates.
Salt Composition of Geftinat 250mg Tablet
- Active Ingredient: Gefitinib
- Strength: 250 mg
Uses of Geftinat 250mg Tablet
- Treatment of non-small cell lung cancer (NSCLC)
Benefits of Geftinat 250mg Tablet
- In Non-Small Cell Lung Cancer: NSCLC is a prevalent form of lung cancer affecting both smokers and non-smokers. Geftinat 250mg Tablet is effective in treating this condition and may be utilized alone or in combination with other therapies. Due to its potency, it is essential for patients to engage in discussions with their healthcare provider regarding the risks and benefits of the treatment. To optimize treatment efficacy, patients are advised to avoid alcohol and maintain proper hydration throughout their therapy.
Side Effects of Geftinat 250mg Tablet
Common side effects may include:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reactions
Most side effects are manageable and may resolve as the body adjusts to the medication. However, patients should inform their doctor if any side effects persist or worsen.
How to Use Geftinat 250mg Tablet
Patients should take Geftinat 250mg Tablet exactly as prescribed by their doctor. It should be swallowed whole and can be taken with or without food; however, consistency in timing is recommended for optimal results.
How Geftinat 250mg Tablet Works
Geftinat 250mg Tablet acts as an anti-cancer agent by blocking the abnormal proteins responsible for signaling cancer cell multiplication. This action effectively inhibits the growth and spread of cancer cells.
Safety Advice for Geftinat 250mg Tablet
- Inform your healthcare provider about any existing medical conditions, especially liver issues or any other ongoing medications.
- Regular monitoring of liver function may be necessary while on treatment.
- Women should utilize effective contraception during treatment and for at least one month post-therapy to avoid pregnancy.
- Patients should stay well-hydrated and report any severe side effects, such as mouth ulcers, vision changes, or breathing difficulties, to their doctor promptly.
